BrainStorm Therapeutics Won the Servier Discovery Award

Read

🌟 Exciting News from BrainStorm Therapeutics! 🌟

We are honored to share that BrainStorm Therapeutics has been selected to join the California Life Sciences (CLS) Innovation & Entrepreneurship FAST California program, as the Servier Discovery Award winner.

This prestigious program provides founders of disruptive, innovative life sciences companies with tailored mentorship from industry experts across pre-clinical development, regulatory strategy, commercialization, and partnering. Over the next 12 weeks, we will work closely with an outstanding advisory team from CLS and Servier to refine our go-to-market strategy, sharpen our regulatory and commercialization plans, strengthen pharmaceutical partnerships, and accelerate our mission to integrate AI and patient-derived brain organoids into the drug discovery process for devastating brain diseases.

We are deeply grateful to CLS and Servier for this opportunity and for their commitment to accelerating innovation in the life sciences. We look forward to leveraging this program to advance our mission: harnessing human data and AI to discover breakthrough medicines for devastating neurological disorders. We are honored to be part of such a distinguished Fall 2025 FAST California cohort.

Onward together! 💡🧠

Other articles in our blog